The filings point to a discounted equity raise ahead — dilution for existing holders. Next thing to watch: a 424B or offering 8-K.
Radar 44 (elevated attention) · dilution pressure elevated · listing risk low · governance risk low · runway 10.1 mo · strongest signal: Offering (424B) (Aug 24, 2026)
What would confirm: 424B5/8-K announcing an offering, ATM sales disclosed in next 10-Q, or Form 4 sales by insiders ahead of it.
What would prove it wrong: Non-dilutive cash event (asset sale, grant, milestone payment), OCF turning positive, or shelf withdrawn (RW).
Direction is stated for existing shareholders (▼ more shares / survival or listing risk; ▲ insiders or holders buying). It is a characterization of the filings, not a forecast or a recommendation.
Independent filings stitched into a thesis, each with what would confirm and what would prove it wrong.
The filings point to a discounted equity raise ahead — dilution for existing holders. Next thing to watch: a 424B or offering 8-K. Cash need (runway 6–12 months) coexists with live selling machinery (shelf effective, offering (424b)). Base case is a discounted raise; the question is when, not if.
No note yet. Notes are written each morning for the top-ranked setups; Pro subscribers get them in full the same day.
Runway = liquidity ÷ monthly operating burn at the latest reported period · balance sheet 84 days old. A financing after the balance-sheet date is the main reason a figure can be stale — check the timeline below for offerings since then.
Last 30 days of filing signals plus current balance-sheet flags, newest first. ▼ pressure · ▲ support · hover a score for its components; every row links to the filing.
| Date | Signal | Evidence | Score |
|---|---|---|---|
| Aug 24, 2026 | ▼ Offering (424B) | 424B3 prospectus supplement 2026-08-24; 2 prior 424B filings in 12m filing | 28 |
| Aug 24, 2026 | ▼ Shelf effective | EFFECT notice 2026-08-24 filing | 21 |
| Jun 30, 2026 | ▼ Runway 6–12 months | ~10.1 months runway: liquidity $15,217,000 (cash $5,509,000 + investments $9,708,000) as of 2026-06-30, burn $18,144,000/yr (latest fiscal-year operating cash flow (quarter too short to annualize) [companyfacts]) filing | 21 |
SDST Stardust Power Inc. · GOVX GeoVax Labs, Inc. · MYSZ My Size, Inc. · SNTI Senti Biosciences Holdings, · GCTK Glucotrack, Inc. · SOAR Volato Group, Inc. · screener →